HCONRES 113
105th Congress
House
Health
Administrative procedure
Air pollution control
Asthma
Chlorofluorocarbons
Commerce
Department of Health and Human Services
Drug industry
Drugs
Environmental Protection
Government Operations and Politics
International Affairs
International environmental cooperation
Law
Medical supplies
Ozone layer depletion
Treaties
Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.
Introduced: July 9, 1997
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 1997
Referred to the Subcommittee on Health and Environment.
Jul 9, 1997
Referred to the House Committee on Commerce.
Jul 9, 1997
Introduced in House
Plain-English summary
Expresses the sense of the Congress that: (1) a specified proposed Food and Drug Administration (FDA) regulation to designate the use of chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs) as nonessential so as to make MDIs using CFCs adulterated devices puts at risk the health of millions of asthma patients and does not contribute measurably to protection of the environment; and (2) the FDA should withdraw its proposal and focus its efforts on implementing existing Montreal Protocol decisions that will facilitate a transition to CFC-free MDIs by 2005.
What's happening now
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
2
Cosponsors
1